Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 29

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 29
---
 these approvals regardless of whether we achieve successful clinical trial results utilizing such therapies.
Even if we do obtain approvals to sell our novel therapies in the United States, these sales may not be as large or as timely as we expect.

We face risks related to compliance with corporate governance laws and financial reporting standards.

We also expect that there will continue to be
new laws, regulations and industry standards concerning privacy, data protection and information security proposed and enacted in various
jurisdictions. Any failure or perceived failure by us to comply with our posted privacy policies, our privacy-related obligations to
users or other third parties or any other legal obligations or regulatory requirements relating to privacy, data protection or information
security may result in governmental investigations or enforcement actions, litigation, claims or public statements against us by consumer
advocacy groups or others and could result in significant liability, cause our users to lose trust in us and otherwise have an adverse
effect on our reputation and business. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations
and policies that are applicable to the businesses of our users may limit the adoption and use of, and reduce the overall demand for,
our platform.

Additionally, if third parties we work with violate
applicable laws, regulations or agreements, such violations may put our users’ data at risk, could result in governmental investigations
or enforcement actions, fines, litigation, claims or public statements against us by consumer advocacy groups or others and could result
in significant liability, cause our users to lose trust in us and otherwise have an adverse effect on our reputation and business. Further,
public scrutiny of or complaints about technology companies or their data handling or data protection practices, even if unrelated to
our business, industry or operations, may lead to increased scrutiny of technology companies, including us, and may cause government
agencies to enact additional regulatory requirements, or to modify their enforcement or investigation activities, which may increase
our costs and risks.

We are increasingly dependent on information technology, and our systems and infrastructure face certain risks, including cybersecurity and data leakage risks.

Significant disruptions to our information technology
systems or breaches of information security could adversely affect our business. In the ordinary course of business, we may collect,
store and transmit large amounts of confidential information, and it is critical that we do so in a secure manner to maintain the confidentiality
and integrity of such information. We also plan to outsource certain elements of our information technology infrastructure; as a result,
we manage independent vendor relationships with third parties who